FertyBiotic Woman Plus

Myo-Inositol 4g Therapeutic Dose · PCOS-Targeted · Metformin-Like Effect

303.47 SAR

Category: Fertility

Clinical Problem

PCOS affects 8–13% of women of reproductive age worldwide. The core pathophysiology: insulin resistance drives hyperinsulinaemia → increased androgen production → anovulation. Metformin improves insulin resistance but carries GI intolerance. FertyBiotic Woman Plus delivers comparable metabolic benefit without side effects.

Target Patient

PCOS diagnosis — all phenotypes

Insulin resistance and hyperandrogenism

Irregular ovulation / anovulation

IVF/ICSI preparation — male partner

Hyperandrogenism with elevated testosterone

Polycystic ovaries on ultrasound

Product Benefits

Insulin Resistance Correction

Myo-Inositol 4g + DCI 421mg at therapeutic PCOS dose. Restores insulin sensitivity — reducing hyperinsulinaemia and androgen production. Metformin-like mechanism without GI effects.

Ovulation Restoration

↑ Ovulation rate and menstrual regularity. Restores LH/FSH ratio. Improves follicular response and oocyte quality in PCOS patients.

IVF Outcome Improvement

↑ IVF implantation rate and clinical pregnancy rate. Reduces risk of OHSS (ovarian hyperstimulation syndrome).

Systemic Inflammation Reduction

6 Billion CFU (double dose) — targets gut-driven systemic inflammation linked to insulin resistance and hyperandrogenism in PCOS.

Treatment Areas

Male infertility · Oligospermia · Asthenospermia · DNA fragmentation · IVF/ICSI preparation · Oxidative seminal stress

PCOS

Insulin resistance

Hyperandrogenism

Anovulation

IVF poor responders

Polycystic ovaries

Product Composition

Myo-Inositol	4g · highest PCOS therapeutic standard dose · restores ovulation
D-Chiro-Inositol	421mg · insulin signalling · androgen cascade suppression
Melatonin	1.8mg · higher dose for PCOS · elevated follicular ROS protection
Vitamin D3	600 IU · FSH receptor sensitivity in PCOS follicles
Selenium	55µg · DNA methylation · antioxidant protection
Folic Acid	400µg · DNA methylation support
Lactobacillus blend	6 Billion CFU (double dose) · systemic inflammation & IR reduction

Clinical Results

4g MI

Therapeutic PCOS Dose

↑ Ovul.

Ovulation Rate

↓ IR

Insulin Resistance

6B CFU

Double Probiotic Dose

1.8mg

Melatonin for PCOS

No GI

Side Effects vs Metformin

Clinical Results

Dosage

1 Stick / Day

30 days per cycle

Duration

Continuous

Repeat per HCP / IVF protocol

IVF Use

3 Months Before Cycle

For folliculogenesis optimisation

Administration

Oral

Dissolve in water, juice, or mix with yogurt

Treatment Areas

PCOS · Insulin resistance · Hyperandrogenism · Anovulation · IVF poor responders · Polycystic ovaries

Frequently Asked Questions

How does FertyBiotic Woman Plus compare to Metformin?

Myo-Inositol at 4g has demonstrated comparable insulin-sensitising effects to Metformin in PCOS patients in randomised trials, without the gastrointestinal side effects (nausea, diarrhea) that cause 30–40% of patients to discontinue Metformin.

What is the difference from FertyBiotic Woman (non-PCOS)?

Woman Plus contains the PCOS therapeutic MI dose (4g vs 1.8g), higher Melatonin (1.8mg vs 1mg), and double probiotics (6B vs 3B CFU) — all targeting the specific metabolic and inflammatory burden of PCOS.

Can it be used during IVF stimulation?

Yes, continue through IVF stimulation as directed by the treating physician. Myo-Inositol may reduce OHSS risk and improve oocyte quality in stimulated PCOS cycles.

Scientific References

Unfer et al. · Myo-Inositol vs Metformin in PCOS — RCT · Gynecological Endocrinology
Raffone et al. · Insulin sensitiser agents in PCOS women — systematic review · Gynecol Endocrinol
Pkhaladze et al. · Inositols reduce hyperandrogenism and improve ovulation — RCT · Facts Views Vis Obgyn

Duration

All clinical data referenced from published peer-reviewed sources. For professional use by qualified healthcare providers only. Not for patient self-diagnosis or treatment.